BFC Planning’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
BFC Planning's KRYS Position: Q3 2026 in Review
BFC Planning increased its Krystal Biotech (KRYS) stake by 400% in Q3 2026, buying an estimated $2.77K and bringing the position to 10 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2845.
BFC Planning first reported a position in KRYS in Q3 2024 and has held it in 6 quarters since. The position peaked at $11.1K in Q3 2024. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- BFC Planning held 10 shares of Krystal Biotech worth $3.33K as of Q3 2026.
- BFC Planning bought 8 Krystal Biotech shares in Q3 2026, an estimated $2.77K.
- Krystal Biotech made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2845 holding.
- BFC Planning first reported a position in Krystal Biotech in Q3 2024 and has held it in 6 quarters since.
- BFC Planning's Krystal Biotech position peaked at $11.1K in Q3 2024.
- 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.